iShares US Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC raised its stake in iShares US Pharmaceuticals ETF (NYSEARCA:IHEGet Rating) by 13.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,700 shares of the company’s stock after acquiring an additional 1,128 shares during the quarter. Janney Montgomery Scott LLC owned approximately 0.43% of iShares US Pharmaceuticals ETF worth $1,645,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of IHE. EWG Elevate Inc. acquired a new position in iShares US Pharmaceuticals ETF in the second quarter valued at approximately $6,354,000. Goldman Sachs Group Inc. raised its stake in shares of iShares US Pharmaceuticals ETF by 255.7% during the 2nd quarter. Goldman Sachs Group Inc. now owns 29,594 shares of the company’s stock worth $5,672,000 after buying an additional 21,275 shares during the period. Atria Wealth Solutions Inc. raised its stake in shares of iShares US Pharmaceuticals ETF by 676.1% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 21,777 shares of the company’s stock worth $4,174,000 after buying an additional 18,971 shares during the period. Merit Financial Group LLC acquired a new position in shares of iShares US Pharmaceuticals ETF during the 2nd quarter worth approximately $3,563,000. Finally, Wells Fargo & Company MN raised its stake in shares of iShares US Pharmaceuticals ETF by 14.5% during the 2nd quarter. Wells Fargo & Company MN now owns 71,446 shares of the company’s stock worth $13,693,000 after buying an additional 9,033 shares during the period.

iShares US Pharmaceuticals ETF Stock Up 0.4 %

Shares of IHE stock opened at $188.72 on Monday. The stock has a 50 day simple moving average of $184.80 and a 200-day simple moving average of $183.06. iShares US Pharmaceuticals ETF has a 1-year low of $166.99 and a 1-year high of $202.77.

iShares US Pharmaceuticals ETF Company Profile

(Get Rating)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Featured Articles

Institutional Ownership by Quarter for iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Receive News & Ratings for iShares US Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.